Homayon J. Arabshahi
A synthesis, in silico, in vitro and in vivo study of thieno[2,3-b]pyridine anticancer analogues
Arabshahi, Homayon J.; van Rensburg, Michelle; Pilkington, Lisa I.; Jeon, Chae Yeon; Song, Mirae; Gridel, Ling-Mey; Leung, Euphemia; Barker, David; Vuica-Ross, Milena; Volcho, Konstantin P.; Zakharenko, Alexandra L.; Lavrik, Olga I.; Reynisson, Jóhannes
Authors
Michelle van Rensburg
Lisa I. Pilkington
Chae Yeon Jeon
Mirae Song
Ling-Mey Gridel
Euphemia Leung
David Barker
Milena Vuica-Ross
Konstantin P. Volcho
Alexandra L. Zakharenko
Olga I. Lavrik
Johannes Reynisson j.reynisson@keele.ac.uk
Abstract
The anticancer activity of the thieno[2,3-b]pyridines was explored by altering the ring size of the cyclo-aliphatic moiety. Five-, six-, seven- and eight-membered derivatives were tested against the NCI60 tumour cell panel. According to this assay the most active derivative 9a has a cyclooctane moiety, which suggests that larger aliphatic ring systems are favourable. For the most sensitive tumour cell line MB-MDA-435, derivative 9a has a GI50 = 70 nM and a LC50 = 925 nM. To explore the biological mechanism of the thieno[2,3-b]pyridines five derivatives were tested against tyrosyl-DNA phosphodiesterase I (TDP1), a phospholipase D enzyme, using a biochemical assay. The most potent derivative for TDP1 was 9d, giving an excellent IC50 at 0.5 ± 0.1 μM. Also, derivative 12 was tested against 97 kinases and no or very limited activity was found, excluding this class of biomolecular targets. Finally, a mouse xenograft study using derivative 12 was encouraging but the tumour size/mass reduction was not quite statistically significant.
Citation
Arabshahi, H. J., van Rensburg, M., Pilkington, L. I., Jeon, C. Y., Song, M., Gridel, L., …Reynisson, J. (in press). A synthesis, in silico, in vitro and in vivo study of thieno[2,3-b]pyridine anticancer analogues. MedChemComm, 6(11), 1987-1997. https://doi.org/10.1039/c5md00245a
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 9, 2015 |
Online Publication Date | Sep 22, 2015 |
Deposit Date | Jun 7, 2023 |
Journal | MedChemComm |
Print ISSN | 2040-2503 |
Electronic ISSN | 2040-2511 |
Publisher | Royal Society of Chemistry |
Peer Reviewed | Peer Reviewed |
Volume | 6 |
Issue | 11 |
Pages | 1987-1997 |
DOI | https://doi.org/10.1039/c5md00245a |
Keywords | Pharmaceutical Science; Biochemistry; Drug Discovery; Molecular Medicine; Pharmacology; Organic Chemistry |
Additional Information | : This document is Similarity Check deposited; : Supplementary Information; : The Royal Society of Chemistry has an exclusive publication licence for this journal; OPEN ACCESS: The accepted version of this article will be made freely available after a 12 month embargo period; : Single-blind; : Received 8 June 2015; Accepted 9 September 2015; Accepted Manuscript published 22 September 2015; Advance Article published 6 October 2015; Version of Record published 4 November 2015 |
You might also like
Accessing active fragments for drug discovery utilising nitroreductase biocatalysis.
(2024)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search